Src inhibitors: drugs for the treatment of osteoporosis, cancer or both?
- 1 December 2000
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 21 (12) , 489-495
- https://doi.org/10.1016/s0165-6147(00)01567-4
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Etk, a Btk Family Tyrosine Kinase, Mediates Cellular Transformation by Linking Src to STAT3 ActivationMolecular and Cellular Biology, 2000
- Emerging therapies for osteoporosisEmerging Drugs, 2000
- Non-transcriptional action of oestradiol and progestin triggers DNA synthesisThe EMBO Journal, 1999
- Src family kinases are required for integrin but not PDGFR signal transductionThe EMBO Journal, 1999
- Crystal Structures of c-Src Reveal Features of Its Autoinhibitory MechanismPublished by Elsevier ,1999
- c-Src, Receptor Tyrosine Kinases, and Human CancerAdvances in Cancer Research, 1999
- Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell TransformationMolecular and Cellular Biology, 1998
- Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potentialOncogene, 1997
- CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASESAnnual Review of Cell and Developmental Biology, 1997
- Vertebrate non‐receptor protein–tyrosine kinase familiesGenes to Cells, 1996